Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity
Spanish-speaking children experience higher rate of obesity than English-speaking children
20 March 2021Several German states want German COVID curbs extended to April: draft plan
21 March 2021Study finds oral testosterone therapy undecanoate is effective, with no liver toxicity
An industry-supported study of an oral testosterone replacement therapy (TRT), testosterone undecanoate (TU, brand name Jatenzo) finds it is an effective, long-term treatment for men with low testosterone levels, with no evidence of liver toxicity. The findings are being presented virtually at ENDO 2021, the Endocrine Society’s annual meeting.
